» Articles » PMID: 35328340

Peptide Human Neutrophil Elastase Inhibitors from Natural Sources: An Overview

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Mar 25
PMID 35328340
Authors
Affiliations
Soon will be listed here.
Abstract

Elastases are a broad group of enzymes involved in the lysis of elastin, the main component of elastic fibres. They are produced and released in the human body, mainly by neutrophils and the pancreas. The imbalance between elastase activity and its endogenous inhibitors can cause different illnesses due to their excessive activity. The main aim of this review is to provide an overview of the latest advancements on the identification, structures and mechanisms of action of peptide human neutrophil elastase inhibitors isolated from natural sources, such as plants, animals, fungi, bacteria and sponges. The discovery of new elastase inhibitors could have a great impact on the pharmaceutical development of novel drugs through the optimization of the natural . Bacteria produce mainly cyclic peptides, while animals provide for long and linear amino acid sequences. Despite their diverse natural sources, these elastase inhibitors show remarkable IC values in a range from nM to μM values, thus representing an interesting starting point for the further development of potent bioactive compounds on human elastase enzymes.

Citing Articles

Computational Approach to Identifying New Chemical Entities as Elastase Inhibitors with Potential Antiaging Effects.

Pitasi G, Brancale A, Floris S, Fais A, Gitto R, De Luca L Int J Mol Sci. 2024; 25(20).

PMID: 39456954 PMC: 11508974. DOI: 10.3390/ijms252011174.


Extracellular traps in peripheral blood mononuclear cell fraction in childhood-onset systemic lupus erythematosus.

Saisorn W, Santiworakul C, Phuengmaung P, Siripen N, Rianthavorn P, Leelahavanichkul A Sci Rep. 2024; 14(1):23177.

PMID: 39369134 PMC: 11455886. DOI: 10.1038/s41598-024-74705-w.


ShSPI Inhibits Thrombosis Formation and Ischemic Stroke In Vivo.

Luan N, Cao H, Wang Y, Zhang H, Lin K, Hu J Int J Mol Sci. 2024; 25(16).

PMID: 39201690 PMC: 11354536. DOI: 10.3390/ijms25169003.


Inhibition of Enzyme and Bacteria Activities in Diabetic Ulcer-like Scenarios via WAAPV-Loaded Electrospun Fibers.

Ribeiro A, Miranda C, Silva A, Mendes F, Silva B, Oliveira B Pharmaceutics. 2024; 16(7).

PMID: 39065608 PMC: 11280037. DOI: 10.3390/pharmaceutics16070911.


Potential Beneficial Effects of Naringin and Naringenin on Long COVID-A Review of the Literature.

Liu S, Zhong M, Wu H, Su W, Wang Y, Li P Microorganisms. 2024; 12(2).

PMID: 38399736 PMC: 10892048. DOI: 10.3390/microorganisms12020332.


References
1.
Matthew S, Ross C, Rocca J, Paul V, Luesch H . Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides. J Nat Prod. 2007; 70(1):124-7. DOI: 10.1021/np060471k. View

2.
Crocetti L, Quinn M, Schepetkin I, Giovannoni M . A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications. Expert Opin Ther Pat. 2019; 29(7):555-578. PMC: 9642779. DOI: 10.1080/13543776.2019.1630379. View

3.
Fujie K, Shinguh Y, Hatanaka H, Shigematsu N, Murai H, Fujita T . FR901277, a novel inhibitor of human leukocyte elastase from Streptomyces resistomycificus. Producing organism, fermentation, isolation, physico-chemical and biological properties. J Antibiot (Tokyo). 1993; 46(6):908-13. DOI: 10.7164/antibiotics.46.908. View

4.
Cui Y, Zhang M, Xu H, Zhang T, Zhang S, Zhao X . Elastase Inhibitor Cyclotheonellazole A: Total Synthesis and In Vivo Biological Evaluation for Acute Lung Injury. J Med Chem. 2022; 65(4):2971-2987. DOI: 10.1021/acs.jmedchem.1c01583. View

5.
Salvador L, Taori K, Biggs J, Jakoncic J, Ostrov D, Paul V . Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells. J Med Chem. 2013; 56(3):1276-90. PMC: 3624605. DOI: 10.1021/jm3017305. View